Medical Developments International Limited
Символ: MVP.AX
ASX
0.59
AUDПазарна цена днес
-2.4258
Съотношение P/E
-0.0085
Коефициент PEG
50.92M
MRK Cap
- 0.00%
Доходност на DIV
Medical Developments International Limited (MVP-AX) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 97.88 | 24.7 | 20.4 | 36.3 | |||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.net-receivables | 26.01 | 8.9 | 6.2 | 5 | |||||||||||||||||||||
balance-sheet.row.inventory | 35.57 | 8.4 | 7.1 | 5.7 | |||||||||||||||||||||
balance-sheet.row.other-current-assets | 3.35 | 0.8 | 0.6 | 0.4 | |||||||||||||||||||||
balance-sheet.row.total-current-assets | 162.8 | 42.8 | 34.4 | 47.4 | |||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 46.89 | 12.1 | 11.6 | 11.7 | |||||||||||||||||||||
balance-sheet.row.goodwill | 7.62 | 3.8 | 3.8 | 4.4 | |||||||||||||||||||||
balance-sheet.row.intangible-assets | 92.91 | 8.5 | 8 | 8.2 | |||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 100.53 | 12.3 | 11.8 | 12.6 | |||||||||||||||||||||
balance-sheet.row.long-term-investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.tax-assets | 45.75 | 16.3 | 14.8 | 2.2 | |||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 22.91 | 29.9 | 32.7 | 30.6 | |||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 248.12 | 66.7 | 67 | 52.8 | |||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-assets | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.account-payables | 47.97 | 13.3 | 9.4 | 3.3 | |||||||||||||||||||||
balance-sheet.row.short-term-debt | 1.41 | 0.4 | 0.3 | 0.3 | |||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
Deferred Revenue Non Current | 27.5 | 1.9 | 21.6 | 21.9 | |||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 17.31 | - | - | - | |||||||||||||||||||||
balance-sheet.row.other-current-liab | 2.73 | 1.6 | 0.7 | 3.3 | |||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 55.4 | 12.6 | 33.6 | 24.9 | |||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 9.08 | 2.2 | 2.5 | 2.7 | |||||||||||||||||||||
balance-sheet.row.total-liab | 108.23 | 28.2 | 44.1 | 31.9 | |||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.common-stock | 393.8 | 105.7 | 77 | 76.9 | |||||||||||||||||||||
balance-sheet.row.retained-earnings | -109.4 | -30.2 | -24.5 | -12.1 | |||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 18.28 | 5.7 | 4.9 | 3.5 | |||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 410.92 | 109.5 | 101.4 | 100.2 | |||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||||
balance-sheet.row.total-equity | 302.68 | 81.3 | 57.3 | 68.3 | |||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 410.92 | - | - | - | |||||||||||||||||||||
Total Investments | 32.04 | -3.8 | -3.8 | -4.4 | |||||||||||||||||||||
balance-sheet.row.total-debt | 10.49 | 2.6 | 2.8 | 3 | |||||||||||||||||||||
balance-sheet.row.net-debt | -87.39 | -22.1 | -17.6 | -33.2 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 | ||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | ||||||||||||||||||||
cash-flows.row.deferred-income-tax | -16.12 | -7.4 | -8.4 | -0.1 | ||||||||||||||||||||
cash-flows.row.stock-based-compensation | 7.08 | 1.3 | 1 | 1.2 | ||||||||||||||||||||
cash-flows.row.change-in-working-capital | -9.12 | -2.5 | -3.6 | -9.9 | ||||||||||||||||||||
cash-flows.row.account-receivables | -1.4 | -2.9 | -2.5 | 1.4 | ||||||||||||||||||||
cash-flows.row.inventory | -3.45 | -1.8 | -1.4 | 0.2 | ||||||||||||||||||||
cash-flows.row.account-payables | 0.48 | 4.8 | 2.3 | 1 | ||||||||||||||||||||
cash-flows.row.other-working-capital | -2.87 | -2.6 | -2.1 | -12.5 | ||||||||||||||||||||
cash-flows.row.other-non-cash-items | 4.83 | -5.4 | 9.8 | 8.9 | ||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -28.71 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.other-investing-activites | -7.54 | 0 | 0 | 0 | ||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.debt-repayment | -0.26 | -0.3 | -0.2 | -0.1 | ||||||||||||||||||||
cash-flows.row.common-stock-issued | 28.57 | 28.3 | 0.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.53 | -1.7 | 0 | -0.7 | ||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -26.4 | -0.1 | -35.5 | ||||||||||||||||||||
cash-flows.row.other-financing-activites | 27.79 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 27.54 | 28.1 | 0.1 | 36.1 | ||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.05 | 0.4 | -0.1 | 0 | ||||||||||||||||||||
cash-flows.row.net-change-in-cash | -12.58 | 4.3 | -15.9 | 20.7 | ||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 97.88 | 24.7 | 20.4 | 36.3 | ||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 110.45 | 20.4 | 36.3 | 15.5 | ||||||||||||||||||||
cash-flows.row.operating-cash-flow | -28.71 | -16.5 | -10.7 | -8.8 | ||||||||||||||||||||
cash-flows.row.capital-expenditure | -11.45 | -7.7 | -5.2 | -6.6 | ||||||||||||||||||||
cash-flows.row.free-cash-flow | -40.16 | -24.2 | -15.9 | -15.4 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 60.19 | 32.3 | 21.9 | 25.3 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 58.93 | 34.9 | 25 | 8.6 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 1.26 | -2.5 | -3.1 | 16.7 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 0.34 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 34.33 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 40.96 | 17.8 | 12.6 | 21.9 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 99.89 | 52.6 | 37.6 | 30.5 | |||||||||||||||||||||
income-statement-row.row.interest-income | 0.93 | 0.7 | 0.5 | 0.1 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 6.63 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 19.1 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 12.96 | 12.8 | -0.2 | -9.7 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 0.19 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 6.14 | 3.1 | 2.9 | 3.7 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -33.56 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -39.7 | -20.3 | -15.7 | -5.2 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -26.73 | -7.5 | -15.9 | -15 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | -5.15 | -1.9 | -3.5 | -2.4 | |||||||||||||||||||||
income-statement-row.row.net-income | -21.58 | -5.6 | -12.4 | -12.6 |
Често задавани въпроси
Какво е Medical Developments International Limited (MVP.AX) общи активи?
Medical Developments International Limited (MVP.AX) общите активи са 109486000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 33494000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.239.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.239.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.574.
Какъв е общият приход на предприятието?
Общият приход е -0.750.
Каква е Medical Developments International Limited (MVP.AX) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -5609000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 2560000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 17757000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 15699000.000.